Trillium Therapeutics, Inc.

Historical 13F Holders

Symbol
TRIL
CUSIP
89620X506
All holders as of
Q4 2021
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q4 2 1.75 k $18.0 k
2021 Q3 216 78.8 M $1.38 B
2021 Q2 155 84.6 M $820 M
2021 Q1 143 75.6 M $812 M
2020 Q4 162 76.5 M $1.12 B
2020 Q3 129 68.0 M $967 M
2020 Q2 96 56.7 M $459 M
2020 Q1 75 60.6 M $244 M
2019 Q4 21 8.67 M $8.91 M
2019 Q3 20 6.83 M $2.10 M
2019 Q2 21 6.70 M $2.20 M
2019 Q1 26 7.12 M $4.69 M
2018 Q4 25 5.82 M $9.95 M
2018 Q3 28 7.04 M $40.8 M
2018 Q2 30 7.13 M $42.8 M
2018 Q1 30 7.52 M $54.2 M
2017 Q4 28 7.30 M $53.1 M
2017 Q3 20 5.09 M $26.2 M
2017 Q2 26 5.34 M $23.2 M
2017 Q1 23 2.34 M $14.4 M
2016 Q4 29 2.65 M $15.0 M
2016 Q3 32 3.47 M $51.3 M
2016 Q2 29 3.07 M $27.6 M
2016 Q1 29 3.19 M $29.5 M
2015 Q4 29 3.88 M $48.9 M
2015 Q3 35 3.98 M $51.8 M
2015 Q2 34 3.21 M $69.9 M
2015 Q1 14 941 k $19.0 M
2014 Q4 8 380 k $3.42 M